Aclarion

Executive Summary

Aclarion is a medical technology company focused on improving the diagnosis and treatment of chronic low back pain through its flagship product, NOCISCAN. NOCISCAN is a non-invasive SaaS platform that leverages magnetic resonance spectroscopy (MRS) to analyze biochemical biomarkers in spinal discs, identifying painful discs with objective data. This technology aims to address the limitations of traditional MRI, which often fails to pinpoint the source of discogenic pain, thereby enabling more targeted treatment planning. By providing clinicians with actionable insights, Aclarion seeks to reduce the diagnostic journey for patients and potentially lower healthcare costs associated with unnecessary procedures. The company, headquartered in Broomfield, Colorado, was founded in 2014 and operates in the medical devices and diagnostics sectors. While still private and in a relatively early stage, Aclarion's innovation has the potential to disrupt the standard of care for one of the most prevalent and costly medical conditions globally.

Upcoming Catalysts (preview)

• Q4 2026Pivotal clinical trial results for NOCISCAN60% success
• Q2 2027FDA 510(k) clearance or De Novo classification50% success
• Q3 2026Strategic partnership with major spine surgery or imaging company40% success